{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:51:18Z","timestamp":1791600678216,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["1783-3\/2018\/FEKUTSRAT"],"award-info":[{"award-number":["1783-3\/2018\/FEKUTSRAT"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["17-27514Y"],"award-info":[{"award-number":["17-27514Y"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["OTKA K-104275"],"award-info":[{"award-number":["OTKA K-104275"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111578","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T20:01:26Z","timestamp":1564689686000},"page":"111578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-8409","authenticated-orcid":false,"given":"Martin","family":"Kr\u00e1tk\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Jan\u010fourek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Baranyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Novotn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Stola\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"B\u0151sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"Vin\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111578_bib1","series-title":"Global Tuberculosis Report","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111578_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2019.111578_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2017.00681","article-title":"New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria","volume":"8","author":"Nasiri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111578_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/QCO.0000000000000386","article-title":"Outbreaks of nontuberculous mycobacteria","volume":"30","author":"Sood","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111578_bib5","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/138161210791293042","article-title":"Prodrug design of phenolic drugs","volume":"16","author":"F\u00e9rriz","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111578_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bmc.2009.12.055","article-title":"Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains","volume":"18","author":"F\u00e9rriz","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bmc.2012.12.011","article-title":"Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis","volume":"21","author":"Gomez","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2015.07.001","article-title":"Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates","volume":"101","author":"Baranyai","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib10","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1016\/j.bmc.2014.05.064","article-title":"Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates","volume":"22","author":"Kr\u00e1tk\u00fd","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/cbdd.13315","article-title":"Dual-protected amino acid derivatives as new antitubercular agents","volume":"92","author":"de Castro","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111578_bib12","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.bmcl.2015.06.060","article-title":"Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs, Bioorg","volume":"25","author":"Kang","year":"2015","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111578_bib13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bmc.2016.02.004","article-title":"Salicylanilide N-monosubstituted carbamates: synthesis and in\u00a0vitro antimicrobial activity","volume":"24","author":"Kr\u00e1tk\u00fd","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21020191","article-title":"Novel cholinesterase inhibitors based on O-aromatic N,N-disubstituted carbamates and thiocarbamates","volume":"21","author":"Kr\u00e1tk\u00fd","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111578_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bioorg.2018.07.017","article-title":"Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase","volume":"80","author":"Kr\u00e1tk\u00fd","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib16","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161211798194521","article-title":"Salicylanilide ester prodrugs as potential antimicrobial agents \u2013 a review","volume":"17","author":"Kr\u00e1tk\u00fd","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111578_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bmc.2008.02.046","article-title":"ATP competitive inhibitors of D-alanine\u2013D-alanine ligase based on protein kinase inhibitor scaffolds","volume":"17","author":"Triola","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib18","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1016\/j.bmc.2010.10.036","article-title":"High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase","volume":"18","author":"Cheng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib19","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1021\/jacs.7b13205","article-title":"Affinity-based screen for inhibitors of bacterial transglycosylase","volume":"140","author":"Wu","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111578_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tube.2012.06.001","article-title":"Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase","volume":"92","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2019.111578_bib21","doi-asserted-by":"crossref","first-page":"703053","DOI":"10.1155\/2014\/703053","article-title":"Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes","volume":"2014","author":"Kr\u00e1tk\u00fd","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejmech.2019.111578_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bmc.2012.10.056","article-title":"Structure\u2013activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling","volume":"21","author":"Lee","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib23","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3390\/molecules18043674","article-title":"Antibacterial activity of salicylanilide 4-(trifluoromethyl)benzoates","volume":"18","author":"Kr\u00e1tk\u00fd","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111578_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2013.12.001","article-title":"Salicylanilide pyrazinoates inhibit in\u00a0vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase","volume":"53","author":"Kr\u00e1tk\u00fd","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.111578_bib25","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.2174\/0929867311209066126","article-title":"Advances in mycobacterial isocitrate lyase targeting and inhibitors","volume":"19","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib26","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.3390\/molecules17089426","article-title":"Antifungal activity of salicylanilides and their esters with 4-(trifluoromethyl)benzoic acid","volume":"17","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111578_bib27","doi-asserted-by":"crossref","first-page":"12812","DOI":"10.3390\/molecules171112812","article-title":"Antimycobacterial assessment of salicylanilide benzoates including multidrug-resistant tuberculosis strains","volume":"17","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111578_bib28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bmc.2014.12.019","article-title":"Synthesis and in\u00a0vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates","volume":"24","author":"Kr\u00e1tk\u00fd","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111578_bib29","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bmcl.2014.02.061","article-title":"Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis","volume":"24","author":"Addla","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111578_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.drudis.2017.04.012","article-title":"Targeting isocitrate lyase for the treatment of latent tuberculosis","volume":"22","author":"Bhusal","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111578_bib31","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/ncomms5306","article-title":"Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis","volume":"5","author":"Nandakumar","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.111578_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2015.12.003","article-title":"Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis","volume":"97","author":"Liu","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2019.111578_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrgastro.2010.134","article-title":"Hepatotoxic effects of therapies for tuberculosis","volume":"7","author":"Senousy","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:59:48Z","timestamp":1777528788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"alternative-id":["S0223523419307123"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111578","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111578"}}